BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Chinese Patent Office
US Army
Medtronic
Argus Health
Johnson and Johnson
Citi
Boehringer Ingelheim
Farmers Insurance

Generated: January 19, 2018

DrugPatentWatch Database Preview

PIROXICAM Drug Profile

« Back to Dashboard

Which patents cover Piroxicam, and what generic alternatives are available?

Piroxicam is a drug marketed by Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Mylan, Mylan Ireland Ltd, PII, SCS, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs. and is included in nineteen NDAs.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

US Patents and Regulatory Information for PIROXICAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PIROXICAM piroxicam CAPSULE;ORAL 074460-001 Sep 29, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms PIROXICAM piroxicam CAPSULE;ORAL 074103-002 Aug 28, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PIROXICAM piroxicam CAPSULE;ORAL 074287-002 May 16, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem Labs Ltd PIROXICAM piroxicam CAPSULE;ORAL 208340-001 Apr 13, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cycle Pharms Ltd PIROXICAM piroxicam CAPSULE;ORAL 073651-001 Feb 26, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pii PIROXICAM piroxicam CAPSULE;ORAL 206136-002 Jun 20, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva PIROXICAM piroxicam CAPSULE;ORAL 074131-001 Dec 11, 1992 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Pharms PIROXICAM piroxicam CAPSULE;ORAL 209256-001 Aug 11, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Egis PIROXICAM piroxicam CAPSULE;ORAL 074808-002 Jul 8, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan PIROXICAM piroxicam CAPSULE;ORAL 074102-001 Jul 31, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Harvard Business School
Healthtrust
US Department of Justice
Citi
Federal Trade Commission
Colorcon
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot